Literature DB >> 18296876

Intracranial peripheral-type primitive neuroectodermal tumor.

Yuichi Furuno1, Shinjitsu Nishimura, Hironaga Kamiyama, Yoshihiro Numagami, Atsushi Saito, Mitsuomi Kaimori, Michiharu Nishijima.   

Abstract

A 15-year-old man presented with headache. Magnetic resonance (MR) imaging revealed a large extraaxial tumor with cyst at the right frontotemporal region. The solid part of the tumor was homogeneously enhanced on T(1)-weighted MR imaging after injection of gadolinium. Digital subtraction angiography of the external carotid artery revealed sunburst appearance corresponding to the tumor, which was fed by the right middle meningeal artery. His headache worsened and computed tomography revealed enlargement of the tumor and intracystic hemorrhage, so emergent operation was performed. At surgery, the tumor strongly adhered to the dural membrane, and was obviously extraaxial. The tumor and cyst were gross totally removed. The attachment site at the dura mater was resected. Histological examination showed solid growth of small round cells with uniform round nuclei and minimal cytoplasm. Immunohistochemical staining showed the cells were positive for MIC-2 (CD99). The MIB-1 labeling index was 53%. The histological diagnosis was peripheral-type primitive neuroectodermal tumor (pPNET). Following surgery, radiation therapy and chemotherapy were given. Ewing's sarcoma and pPNET form a family of small round cell tumors arising in the bone or soft tissue. MIC-2 is a useful marker in the differential diagnosis. Good prognosis may be attained if complete surgical excision of intracranial pPNET is achieved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296876     DOI: 10.2176/nmc.48.72

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  8 in total

1.  The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.

Authors:  Ciğdem Vural; Omer Uluoğlu; Nalan Akyürek; Aynur Oğuz; Ceyda Karadeniz
Journal:  Pathol Oncol Res       Date:  2011-01-26       Impact factor: 3.201

2.  Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor in the Cerebellopontine Angle : Diagnosis and Treatment.

Authors:  Ho Yong Choi; Yong Hwy Kim; Jee Hyun Kim; In Ah Kim; Gheeyoung Choe; Chae-Yong Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30

3.  Primary Bone Tumors of the Skull: Spectrum of 125 Cases, with Review of Literature.

Authors:  Aanchal Kakkar; Aruna Nambirajan; Vaishali Suri; Chitra Sarkar; Shashank S Kale; Manmohan Singh; Mehar Chand Sharma
Journal:  J Neurol Surg B Skull Base       Date:  2016-01-04

4.  Intraspinal primitive neuroectodermal tumor in a man with neurofibromatosis type 1: Case report and review of the literature.

Authors:  Celene B Mulholland; Garni Barkhoudarian; Marcia E Cornford; Duncan Q McBride
Journal:  Surg Neurol Int       Date:  2011-10-29

5.  Peripheral primitive neuroectodermal tumor of the pelvis.

Authors:  Zohreh Yousefi; Nourieh Sharifhi; Malihe Hasanzadeh; Mansoureh Mottaghi; Somayeh Bolandy
Journal:  Iran J Med Sci       Date:  2014-01

6.  A rare case of pelvic primitive neuroectodermal tumor with misleading symptoms: A case report.

Authors:  Kusay Ayoub; Ammar Niazi; Baraa Shebli; Rand Batal; Hamed Kozom; Lina Ghabreau; Nihad Mahli
Journal:  Ann Med Surg (Lond)       Date:  2020-05-16

7.  Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report.

Authors:  Yang Zhang; Hongsheng Li; Zongjuan Li; Ming Liu; Linke Yang; Liyuan Fan; Chengsuo Huang; Baosheng Li
Journal:  Onco Targets Ther       Date:  2016-06-02       Impact factor: 4.147

Review 8.  Primary intracranial dural-based Ewing sarcoma/peripheral primitive neuroectodermal tumor mimicking a meningioma: A rare tumor with review of literature.

Authors:  Vikul Kumar; Anshu Singh; Vivek Sharma; Mohan Kumar
Journal:  Asian J Neurosurg       Date:  2017 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.